Regulus Therapeutics Stock News

SAN DIEGO , May 17, 2022 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (th

These penny stocks all have 10x potential or greater during the remainder of 2022. They are risky but relatively straightforward.

Here are three tips for trading penny stocks during a bear market The post How to Trade Penny Stocks When the Stock Market Crashes appeared first on Penny Stocks to Buy, Picks, News and Information |

Regulus Therapeutics, Inc. (NASDAQ:RGLS ) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Crispina Calsada - CFO Joseph Hagan - President, CEO & Director Conference Call

The FDA accepts Regulus' (RGLS) IND application for RGLS8429 to treat autosomal dominant polycystic kidney disease. The company plans to begin a phase I study in second-quarter 2022.

Why these penny stocks climbed during trading today The post Top Penny Stocks to Watch as AFI Stock Shoots Up By Over 230% appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto

Regulus Therapeutics Inc. (RGLS) CEO Jay Hagan on Q4 2021 Results - Earnings Call Transcript

Regulus Therapeutics press release (RGLS): Q4 GAAP EPS of -$0.07.As of December 31, 2021, Regulus had $60.4M in cash and cash equivalents.

SAN DIEGO, March 10, 2022 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced its financial results for the fourth quarter…

Regulus Therapeutics (NASDAQ:RGLS) is scheduled to announce Q4 earnings results on Wednesday, March 9th, after market close.The consensus EPS Estimate is -$0.07 (-133.3% Y/Y) and…

In the last trading session, 1.85 million shares of the Regulus Therapeutics Inc. (NASDAQ:RGLS) were traded, and its beta was 2.03. Most recently the company’s share price was $0.29, and it changed around $0.0 or 1.18% from the last close, which brings the market valuation of the company to $24.69M. RGLS currently trades at a … Why Regulus Therapeutics Inc. (NASDAQ: RGLS) Stock Should Not Be Taken For Granted By Investors In 2022 Read More »

SAN DIEGO , March 3, 2022 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that it has scheduled its fourth quarter and year-end

SAN DIEGO, March 3, 2022 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (th

Gainers ECMOHO Limited (NASDAQ: MOHO ) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP ) shares jumped 39.2% to close at $2.06 after dipping 37% on Tuesday. Nordstrom, Inc. (NYSE: JWN ) shares jumped 37.8% to settle at $26.93 after the company reported better-than-expected Q4 EPS and sales results. The company also issued FY22 guidance. Regulus Therapeutics Inc. (NASDAQ: RGLS ) gained 35.6% to close at $0.3050. Indonesia Energy Corporation Limited (NASDAQ: INDO ) surged 34.5% to close at $14.50. Trevi Therapeutics, Inc. (NASDAQ: TRVI ) gained 32% to settle at $1.15. Arlo Technologies, Inc. (NYSE: ARLO ) rose 28.9% to close at $11.19 after the company reported better-than-expected Q4 results. The company also issued Q1 sales guidance above analyst estimates. Rocky Brands, Inc. (NASDAQ: RCKY ) climbed 26.6% to close at $47.47 following better-than-expected Q4 results. China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC ) gained 26.1% to close at $0.2181.